Gilder Gagnon Howe & Co’s Sana Biotechnology SANA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$276K	Buy	95,796 +1,724	+2%	+$6.79K	﹤0.01%	246
2025 Q4	$383K	Buy	94,072 +2,533	+3%	+$11.3K	﹤0.01%	240
2025 Q3	$325K	Buy	+91,539	New	+$331K	﹤0.01%	246
2024 Q4	–	Sell	-69,291	Closed	-$288K	–	271
2024 Q3	$288K	Buy	+69,291	New	+$364K	﹤0.01%	244
2024 Q2	–	Sell	-84,259	Closed	-$843K	–	271
2024 Q1	$843K	Buy	+84,259	New	+$631K	0.01%	218
2022 Q2	–	Sell	-83,775	Closed	-$692K	–	272
2022 Q1	$692K	Buy	+83,775	New	+$677K	0.01%	260
2021 Q4	–	Sell	-402,961	Closed	-$9.07M	–	423
2021 Q3	$9.07M	Buy	402,961 +542	+0.1%	+$11.4K	0.05%	210
2021 Q2	$7.91M	Sell	402,419 -539,475	-57%	-$12.2M	0.04%	231
2021 Q1	$31.5M	Buy	+941,894	New	+$30.7M	0.17%	126